Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (2)
  • Drug Metabolite
    (1)
  • P2Y Receptor
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Metabolism
    (3)
  • Cardiovascular System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

udp-β-d-glucose

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Natural Products
    1
    TargetMol | Natural_Products
  • Oligonucleotides
    2
    TargetMol | All_Pathways
  • UDP-β-D-Glucose (sodium salt)
    T378997333-33-7
    UDP-β-D-Glucose is the stereoisomer of UDP-α-D-glucose (sodium salt) . The activities of the UDP-β-D-glucose isomer are not known.
    • $195
    35 days
    Size
    QTY
  • UDP-α-D-Glucose sodium hydrate
    UDP-α-D-Glucose disodium xhydrate
    T37898
    UDP-α-D-Glucose sodium hydrate is an endogenous metabolite and a pyrimidine nucleotide sugar, involved in glycosylation reactions during metabolic processes, serving as a precursor and substrate for enzymes in the synthesis of glycogen and sucrose.
    • $223
    35 days
    Size
    QTY
  • Uridine diphosphate glucose
    Uridine 5′-diphosphoglucose, UDP-D-Glucose
    T19599133-89-1
    Uridine diphosphate glucose (UDP-glucose) is a pyrimidine nucleotide sugar, serving as a precursor for oligosaccharides, polysaccharides, glycoproteins, and glycolipids containing glucose. It is a key intermediate in carbohydrate metabolism and participates in numerous enzymatic reactions, acting as a P2Y14 agonist.
    • $293
    In Stock
    Size
    QTY
  • 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
    1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
    T38213114200-59-8
    1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides . They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines completely reduce neurite outgrowth and induce death of LA-N-2 cells at concentrations of 10 and 50 μM, respectively. They also decrease the activity of glucocerebrosidase in LA-N-2 cells in a dose-dependent manner. Glucosylsphingosine levels are elevated in patients with Gaucher's disease, both in the spleen (in types 1, 2, and 3) and brain (type 2 and 3); thus, glucosylsphingosine has been used as a key biomarker of the disease. This product contains 1-β-D-glucosylsphingadienine isolated from plants.
    • $423
    35 days
    Size
    QTY